Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

67

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions
Gastric Adenocarcinoma
Interventions
PROCEDURE

gastrectomy

radical total/subtotal gastrectomy with D2 lymph node dissection

PROCEDURE

sampling of peritoneal washing aspirate

After thoroughly examination of the peritoneal cavity revealing the absence of peritoneal dissemination, the peritoneal cavity was washed with 200 ml of saline, and at least one third was aspirated from several regions of the peritoneal cavity, including near the primary tumor, the left and right subphrenic areas and the pouch of Douglas with suction tubes to a clean bottle and designated as the peritoneal sample for determination of peritoneal levels of CEA and CA 19-9.

Trial Locations (1)

34093

Mustafa Hasbahceci, Istanbul

All Listed Sponsors
lead

Bezmialem Vakif University

OTHER

NCT02801955 - Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter